Intercept Pharma (ICPT)
NASDAQ:ICPT
Holding ICPT?
Track your performance easily

Intercept Pharma (ICPT) Stock News & Sentiment

1,453 Followers
Intercept announces new findings from long-term extension of POISE trial
Premium
The Fly
Intercept announces new findings from long-term extension of POISE trial
1y ago
Alfasigma completes acquisition of Intercept Pharmaceuticals, Inc.
Premium
Press Releases
Alfasigma completes acquisition of Intercept Pharmaceuticals, Inc.
1y ago
Alfasigma completes acquisition of Intercept
Premium
The Fly
Alfasigma completes acquisition of Intercept
1y ago
CHMP starts review of Intercept’s Ocaliva
Premium
The Fly
CHMP starts review of Intercept’s Ocaliva
1y ago
Intercept management to meet with Oppenheimer
Premium
The Fly
Intercept management to meet with Oppenheimer
1y ago
Intercept management to meet with Oppenheimer
Premium
The Fly
Intercept management to meet with Oppenheimer
1y ago
Intercept management to meet with Oppenheimer
Premium
The Fly
Intercept management to meet with Oppenheimer
1y ago
More ICPT News >

News Score - Last 7 Days

Neutral
ICPT
Sector Average
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is ICPT’s Media Buzz Sentiment?
Currently, no data Available
What is ICPT’s weekly average amount of articles?
Currently, no data Available
What is ICPT’s News Sentiment?
Currently, no data Available
Healthcare Stocks that are Trending in the News
NNVCNanoViricides
SLDBSolid Biosciences
GANXGain Therapeutics
HRTXHeron Therapeutics
FIXXHomology Medicines
Showing the stocks with the most bullish news sentiment over the past week
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis